Reply by Authors

J Urol. 2022 Nov;208(5):1036. doi: 10.1097/JU.0000000000002885.02. Epub 2022 Sep 12.

Paul Doan^{1

2}, Matthijs J Scheltema^{1

2

3}, Amer Amin^{1

2}, Ron Shnier⁴, Bart Geboers^{1

2

5}, William Gondoputro^{1

2}, Daniel Moses⁶, Pim J van Leeuwen³, Anne Maree Haynes², Jayne Matthews², Phillip Brenner¹, Gordon O'Neill¹, Carlo Yuen¹, Warick Delprado⁷, Phillip Stricker¹, James Thompson^{1

2}

¹ St. Vincent's Prostate Cancer Centre, Department of Urology, Darlinghurst, Sydney, New South Wales, Australia.
² Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.
³ Department of Urology, Amsterdam University Medical Centers (VUmc), Amsterdam, The Netherlands.
⁴ I-MED Radiology, Sydney, New South Wales, Australia.
⁵ Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers (VUmc), Amsterdam, The Netherlands.
⁶ Spectrum Medical Imaging, Sydney, New South Wales, Australia.
⁷ Douglas Hanly Moir Pathology, Sydney, New South Wales, Australia.

No abstract available

Publication types